Sub1 - SUB1 regulator of transcription Gene
Also Known as Rpo2tc1
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 192269
Summary
Predicted to enable DNA binding activity; identical protein binding activity; and transcription coactivator activity. Predicted to be involved in negative regulation of DNA metabolic process and positive regulation of transcription initiation from RNA polymerase II promoter. Predicted to act upstream of or within SMAD protein signal transduction. Located in nucleus. Orthologous to human SUB1 (SUB1 regulator of transcription). [provided by Alliance of Genome Resources, Apr 2022]
Sub1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001009618.1 | NP_001009618.1 | activated RNA polymerase II transcriptional coactivator p15 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
activated RNA polymerase II transcriptional coactivator p15 |
|
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-13956A | (R)-Pioglitazone-d1 | / | Phase 2 | |
| HY-W865379 | (S)-Avadomide-d1 | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(401)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-15176B | Pyridostatin TFA | 99.17% | Unkown | |
| HY-B0892S4 | Benzyl alcohol-d1 | 95.66% | Unkown | |
| HY-W142820S | 1,1,3,3-Tetraethoxypropane-d2 | 99.23% | Unkown | |
| HY-B0228S | Adenosine-d1 | 99.97% | Unkown | |
| HY-130462S | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31 | ≥99.0% | Unkown | |
| HY-146726S | Tripentadecanoin-d29 | 99.24% | Unkown | |
| HY-W040193S | DSPC-d70 | 99.93% | Unkown | |
| HY-15176C | Pyridostatin trihydrochloride | 99.85% | Unkown | |
| HY-13966S | 2-Deoxy-D-glucose-d1 | 98.0% | Unkown | |
| HY-B0389S2 | D-Glucose-d12-1 | 99.47% | Unkown | |
| HY-W013049S4 | Docosanoic acid-d4-1 | Inhibitor | 99.26% | Unkown |
| HY-90006S | 5-Fluorouracil-d1 | 99.9% | Unkown | |
| HY-W050145S | Levoglucosan-d7 | 99.90% | Unkown | |
| HY-113123S1 | LysoPC(14:0/0:0)-d7 | 95.40% | Unkown | |
| HY-B0151S2 | Pregnenolone-d4-1 | 99.34% | Unkown | |
| HY-B0152S | Adenine-d1 | Chemical | 99.91% | Unkown |
| HY-Y1275S | N-Methylpyrrolidone-d9 | 98% | Unkown | |
| HY-Y0921S | (±)-1,2-Propanediol-d8 | 99.55% | Unkown | |
| HY-122277S | 1'-Hydroxy bufuralol-d9 | 99.9% | Unkown | |
| HY-Y1039S1 | 1-Stearoyl-rac-glycerol-d35 | 99.91% | Unkown | |
| HY-143671S | 1-Stearoyl-2-arachidonoyl-sn-glycero-3-PE-d11 | 99.0% | Unkown | |
| HY-15780S1 | Brexpiprazole-d8-1 | 96.48% | Unkown | |
| HY-N7092S11 | D-Fructose-d-1 | 98.0% | Unkown | |
| HY-W768340 | Sucrose-13C6-1 | 99.90% | Unkown | |
| HY-125783S1 | 1-Palmitoyl-sn-glycero-3-phosphocholine-d31 | 99.94% | Unkown | |
| HY-125783S3 | 1-Palmitoyl-sn-glycero-3-phosphocholine-d9-1 | 95.0% | Unkown | |
| HY-125771S | 1-Stearoyl-sn-glycero-3-phosphocholine-d35 | 99% | Unkown | |
| HY-B0389S1 | D-Glucose-d1 | 99.86% | Unkown | |
| HY-B0402S | Amantadine-d15 | 98.13% | Unkown | |
| HY-W014286S | 1,3-Diphenylurea-d10 | 99% | Unkown | |
| HY-W242724 | 1,4-Dibromo-butane-d8 | 99.91% | Unkown | |
| HY-Y0921S2 | (±)-1,2-Propanediol-d6 | 99.97% | Unkown | |
| HY-113424AS | 1,2-Dioleoyl-sn-glycero-3-phosphocholine-d9 | 98.0% | Unkown | |
| HY-W032013S | 1-Octanol-d17 | 99.09% | Unkown | |
| HY-W050145S2 | Levoglucosan-13C6 | 99.7% | Unkown | |
| HY-100442S1 | Paquinimod-d5-1 | Inhibitor | 98.19% | Unkown |
| HY-10162S3 | Olaparib-d4-1 | 98.82% | Unkown | |
| HY-10585S4 | Valproic acid-d4-1 | 99.5% | Unkown | |
| HY-113139S | 1-Methylinosine-d3 | 99.0% | Unkown | |
| HY-13936S | 1-Methylimidazoleacetic acid-d3 | / | Unkown | |
| HY-14648S5 | Dexamethasone-d3-1 | 98.02% | Unkown | |
| HY-76025S | 1,4-Dibromobenzene-d4 | 99.94% | Unkown | |
| HY-B0234S4 | Estrone-d2-1 | Agonist | 99.75% | Unkown |
| HY-B0389S8 | D-Glucose-d1-4 | 98.0% | Unkown | |
| HY-B0166S8 | L-Ascorbic acid-13C6-1 | 99.37% | Unkown | |
| HY-B0389S7 | D-Glucose-d1-3 | 99.90% | Unkown | |
| HY-N0229S16 | L-Alanine-d3-1 | 99.0% | Unkown | |
| HY-W004051S | 1-Bromo-2-chlorobenzene-d4 | 99.75% | Unkown | |
| HY-W089832S | 1,1-Dimethylurea-d6 | 99.61% | Unkown | |
| HY-W097453S2 | 6-(Methylthio)purine-d3-1 | 99.56% | Unkown | |
| HY-N0488S1 | Vincristine-d3-1 sulfate | 99.59% | Unkown | |
| HY-107343S1 | Docosahexaenoic acid ethyl ester-d5-1 | / | Unkown | |
| HY-109128S2 | Danicamtiv-d3-1 | / | Unkown | |
| HY-109506S3 | DPPC-d9-1 | ≥99.0% | Unkown | |
| HY-115702S | 1-Palmityl-2-O-acetyl-3-glyceryl phosphorylcholine-d4 | Agonist | ≥99.0% | Unkown |
| HY-12222S1 | Obeticholic acid-d4-1 | Agonist | 99.84% | Unkown |
| HY-15025S2 | Sildenafil-d3-1 | 99.47% | Unkown | |
| HY-153939S | Idasanutlin-d3-1 | 99.57% | Unkown | |
| HY-17376S1 | Ezetimibe-d4-1 | 99.26% | Unkown | |
| HY-34705S | Dimethyl sulfoxide-d6 | 99.83% | Unkown | |
| HY-70057S1 | Safinamide-d4-1 | Inhibitor | 98.90% | Unkown |
| HY-A0070AS2 | Liothyronine-13C6-1 | Agonist | 98.06% | Unkown |
| HY-B0228S8 | Adenosine-d1-2 | 99.72% | Unkown | |
| HY-B0389S4 | D-Glucose-d1-2 | 99.92% | Unkown | |
| HY-B0402S1 | Amantadine-d6 | 99.86% | Unkown | |
| HY-B0511S | Biotin-d2-1 | 99.65% | Unkown | |
| HY-B1411S1 | i-Inositol-d1 | 99.46% | Unkown | |
| HY-N0210S11 | D-Galactose-d2-1 | 99.9% | Unkown | |
| HY-N0210S7 | D-Galactose-d1-2 | / | Unkown | |
| HY-N0229S4 | L-Alanine-13C,d1 | 99.96% | Unkown | |
| HY-W004263S | 1-Eicosanol-d41 | 98.8% | Unkown | |
| HY-W004292S | 1-Undecanol-d23 | 98.2% | Unkown | |
| HY-W009719S | 1-Bromo-2,3-dichlorobenzene-d3 | / | Unkown | |
| HY-W010004S | 1-Bromo-3-chlorobenzene-d4 | / | Unkown | |
| HY-W013504S | 1-Bromo-4-(trifluoromethyl)benzene-d4 | / | Unkown | |
| HY-W032013S1 | 1-Octanol-d2 | 99.0% | Unkown | |
| HY-W654064 | Azithromycin-13C,d3-1 | 99.9% | Unkown | |
| HY-W726845 | 1-Methyl-4-nitrosopiperazine-d11 | 97.57% | Unkown | |
| HY-Y0308S | Phosphate dibasic-d1sodium | 99.0% | Unkown | |
| HY-Y1004S4 | 1-Decanol-d4 | 99.75% | Unkown | |
| HY-Y1217S1 | 1-Cyclohexanol-d11 | / | Unkown | |
| HY-109541S2 | Colfosceril miristate-d9 | 99.0% | Unkown | |
| HY-113136S | 1-Methylguanosine-d3 | 99.50% | Unkown | |
| HY-33948S | 1-Amino-2-methylpropan-2-ol-d6 | / | Unkown | |
| HY-B0260S6 | Methylprednisolone-d3-1 | / | Unkown | |
| HY-W012934S | 1-Ethylpyrrolidin-2-one-d5 | / | Unkown | |
| HY-W015301S1 | Dimethyl adipate-d4-1 | 99.40% | Unkown | |
| HY-W040193S3 | DSPC-d83 | 99.0% | Unkown | |
| HY-W040193S4 | DSPC-d4 | 99.0% | Unkown | |
| HY-W1115209 | 1,3,5-Tribromo-2-iodobenzene-d2 | / | Unkown | |
| HY-W115741S | 1-Phenylethanamine-d3 | / | Unkown | |
| HY-W725472 | 1,3-Dibromobenzene-d4 | / | Unkown | |
| HY-Y0566S | 1,4-Diazabicyclo[2.2.2]octane-d12 | 99.60% | Unkown | |
| HY-Y1052S | N-Dodecylbenzene-d30 | 98.1% | Unkown | |
| HY-Y1806S1 | 1,3-Dibromopropane-d6 | / | Unkown | |
| HY-109025AS2 | Baloxavir-d1 | Inhibitor | / | Unkown |
| HY-12215S2 | Deulorlatinib | 99.84% | Unkown | |
| HY-125783S2 | 1-Palmitoyl-sn-glycero-3-phosphocholine-d49 | 99% | Unkown | |
| HY-W015913S4 | Pyruvic acid-13C2-1 sodium | 99.0% | Unkown | |
| HY-Y0479S3 | L-Lactic acid-2-13C1 | Inhibitor | / | Unkown |
| HY-15029S1 | (±)-Naproxen-d3-1 | / | Unkown | |
| HY-W013376S | Norcyclizine-d8 | / | Unkown | |
| HY-10002AS | (1S)-Calcitriol-d3 | / | Unkown | |
| HY-10002AS2 | (1S)-Calcitriol-d6 | / | Unkown | |
| HY-10003S | Alfacalcidol-d7 | Activator | / | Unkown |
| HY-100441S1 | Treprostinil-13C2,d1 | Inhibitor | / | Unkown |
| HY-100641S1 | 4-Hydroxytolbutamide-d9-1 | / | Unkown | |
| HY-10284S3 | Linagliptin-d3-1 | / | Unkown | |
| HY-10585AS2 | Valproic acid-d4-1 sodium | / | Unkown | |
| HY-107737S | 1,2-DLPC-d55 | / | Unkown | |
| HY-107737S2 | 1,2-DLPC-d46 | / | Unkown | |
| HY-107737S3 | 1,2-DLPC-d9 | / | Unkown | |
| HY-10846S1 | Delamanid-d4-1 | / | Unkown | |
| HY-108506S2 | Licarbazepine-d4-1 | Inhibitor | 99.28% | Unkown |
| HY-109127S | Berotralstat-d4-1 | Inhibitor | / | Unkown |
| HY-109541S | Colfosceril miristate-d58 | 99.3% | Unkown | |
| HY-109541S1 | Colfosceril miristate-d4 | / | Unkown | |
| HY-109541S3 | Colfosceril miristate-d13 | / | Unkown | |
| HY-109541S4 | Colfosceril miristate-d63 | / | Unkown | |
| HY-109541S5 | Colfosceril miristate-d67 | 99.0% | Unkown | |
| HY-11018S1 | Risperidone-d4-1 | / | Unkown | |
| HY-112005S | DOPE-d62 | / | Unkown | |
| HY-112530S | 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine-d70 | 99.0% | Unkown | |
| HY-113958S1 | Difethialone-d4-1 | Inhibitor | / | Unkown |
| HY-114041S1 | Resolvin E1-d4-1 | / | Unkown | |
| HY-115705S | 1,2,3-Tri-10(Z)-Heptadecenoyl Glycerol-d5 | / | Unkown | |
| HY-122056S | 1,2-Diheptanoyl-SN-glycero-3-phosphocholine-d35 | / | Unkown | |
| HY-122056S1 | 1,2-Diheptanoyl-SN-glycero-3-phosphocholine-d26 | / | Unkown | |
| HY-122272S2 | Paroxetine-d6-1 | / | Unkown | |
| HY-122426S1 | 1-Bromoundecane-d3 | / | Unkown | |
| HY-122426S2 | 1-Bromoundecane-d4 | 98.8% | Unkown | |
| HY-12516S2 | Desogestrel-13C2,d2-1 | / | Unkown | |
| HY-125783S | 1-Palmitoyl-sn-glycero-3-phosphocholine-d9 | / | Unkown | |
| HY-12650S | Mirogabalin-13C2,d1 (Mixture of Diastereomers) | / | Unkown | |
| HY-126967AS | 1-Palmitoyl-sn-glycerol 3-phosphate-d9 | / | Unkown | |
| HY-12987S2 | Pimozide-d4-1 | Inhibitor | / | Unkown |
| HY-130462S1 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d82 | 99% | Unkown | |
| HY-130462S4 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d9 | / | Unkown | |
| HY-130462S5 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d62 | / | Unkown | |
| HY-13571S3 | Betamethasone dipropionate-d6-1 | / | Unkown | |
| HY-135810S1 | Cletoquine-d4-1 | Inhibitor | / | Unkown |
| HY-13593S1 | Chlorambucil-d8-1 | / | Unkown | |
| HY-139609AS | (1R,3r,5S)-Camonsertib-d3 | / | Unkown | |
| HY-141919S | 1-Bromo-4-iodobenzene-13C6 | / | Unkown | |
| HY-142555S | Bisphenol A monosulfate-d6 sodium | / | Unkown | |
| HY-14281S2 | Trilostane-d3-1 | / | Unkown | |
| HY-14444S | Plinabulin-d1 | Inhibitor | / | Unkown |
| HY-145547S | 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine-d27 | / | Unkown | |
| HY-14648S1 | Dexamethasone-d5-1 | / | Unkown | |
| HY-14656S4 | Diltiazem-d4-1 hydrochloride | Antagonist | / | Unkown |
| HY-146737S | Tripentadecanoin-d5 | / | Unkown | |
| HY-146881S | Colfosceril miristate-d27 | 99.0% | Unkown | |
| HY-146894S | DSPC-d35 | 99.0% | Unkown | |
| HY-14956S1 | Nemonoxacin-d3-1 | Inhibitor | / | Unkown |
| HY-151997S | 1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3 | / | Unkown | |
| HY-152070S1 | Demethylmaprotiline-d2-1 | / | Unkown | |
| HY-15592S2 | Cabotegravir-d3-1 | Inhibitor | / | Unkown |
| HY-15917S1 | DL-Dithiothreitol-d10-1 | Inhibitor | / | Unkown |
| HY-160099S1 | 20-5,14-HEDE-d2-1 | / | Unkown | |
| HY-17386S2 | Rosiglitazone-d4-1 | / | Unkown | |
| HY-17430S1 | Amprenavir-d4-1 | Inhibitor | / | Unkown |
| HY-178403S | 1,3-Diethyl-1,3-diphenylurea-d10-1 | / | Unkown | |
| HY-178703S | 1,2-Diheptanoyl-SN-glycero-3-phosphocholine-d9 | / | Unkown | |
| HY-178735S | 1,2-Dioleoyl-sn-glycero-3-phosphocholine-d62 | / | Unkown | |
| HY-178736S | 1,2-Dilauroyl-sn-glycero-3-phosphoethanolamine-d46 | / | Unkown | |
| HY-178758S | 1-Palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine-d66 | / | Unkown | |
| HY-178787S | POPG-d62 | / | Unkown | |
| HY-178791S | 1,2-Diheptanoyl-sn-glycero-3-phosphoethanolamine-d26 | / | Unkown | |
| HY-178810S | 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine-d62 ammonium | / | Unkown | |
| HY-18341S4 | L-Thyroxine-13C6-1 | / | Unkown | |
| HY-19696S2 | Tauroursodeoxycholate-d4-1 | Inhibitor | / | Unkown |
| HY-23188 | Loratadine-d5-1 | / | Unkown | |
| HY-34123S | N-(2-Bromoethyl)phthalimide-d4 | / | Unkown | |
| HY-34444S | 1,1-Dioxothiolan-d8 | 99.9% | Unkown | |
| HY-41676S | 4-Chlorobenzonitrile-d4 | / | Unkown | |
| HY-41681S | 6-Chloro-1-hexanol-d6 | 98% | Unkown | |
| HY-50898S3 | Lapatinib-d4-1 | / | Unkown | |
| HY-59354S1 | 1,2-Dihydropyridazine-3,6-dione-3,4,5,6-13C4 | Inhibitor | / | Unkown |
| HY-66008S1 | N-Acetyl mesalazine-d3-1 | / | Unkown | |
| HY-66011AS3 | Moxifloxacin-d3-1 hydrochloride | Inhibitor | / | Unkown |
| HY-79779S1 | 1-Bromo-4-(bromomethyl)benzene-d4 | / | Unkown | |
| HY-A0042S2 | Rufinamide-15N,d2-1 | Inhibitor | / | Unkown |
| HY-A0052S | (1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4 | / | Unkown | |
| HY-A0095S1 | Flibanserin-d4-1 | 99.28% | Unkown | |
| HY-B0111S1 | Drospirenone-d4-1 | Agonist | / | Unkown |
| HY-B0113S1 | Omeprazole-d3-1 | Inhibitor | 95.09% | Unkown |
| HY-B0114S1 | Oxcarbazepine-d4-1 | / | Unkown | |
| HY-B0158S3 | Cytidine-d2-1 | / | Unkown | |
| HY-B0158S4 | Cytidine-d1 | / | Unkown | |
| HY-B0196S1 | Venlafaxine-d6-1 | Inhibitor | 99.9% | Unkown |
| HY-B0223S4 | Albendazole-d3-1 | / | Unkown | |
| HY-B0228S7 | Adenosine-d1-1 | 99.5% | Unkown | |
| HY-B0389S18 | D-Glucose-13C3-1 | / | Unkown | |
| HY-B0389S23 | D-Glucose-d2-1 | / | Unkown | |
| HY-B0389S25 | D-Glucose-13C,d1 | / | Unkown | |
| HY-B0389S3 | D-Glucose-d1-1 | / | Unkown | |
| HY-B0400S7 | D-Sorbitol-d1-2 | / | Unkown | |
| HY-B0400S8 | D-Sorbitol-d2-1 | / | Unkown | |
| HY-B0412S4 | Estriol-d3-1 | Antagonist | / | Unkown |
| HY-B0451AS3 | Dopamine-d2-1 hydrochloride | / | Unkown | |
| HY-B0456S1 | Riboflavin-5-Phosphate-13C4,15N2-1 | / | Unkown | |
| HY-B0561S2 | Spironolactone-d3-1 | / | Unkown | |
| HY-B0763S2 | Ibudilast-d7-1 | / | Unkown | |
| HY-B0896S1 | Triacetin-d5 | Inhibitor | / | Unkown |
| HY-B0896S2 | Triacetin-d9 | / | Unkown | |
| HY-B0901S1 | Bromperidol-d4-1 | Inhibitor | / | Unkown |
| HY-B1659S3 | Glycerol-d1 | / | Unkown | |
| HY-B1716S1 | L-5-Hydroxytryptophan-d3-1 | / | Unkown | |
| HY-G0016S1 | N-Acetyl dapsone-d4-1 | / | Unkown | |
| HY-N0131S1 | Stigmasterol-d5-1 | 99.90% | Unkown | |
| HY-N0210S12 | D-Galactose-13C,d1 | / | Unkown | |
| HY-N0210S5 | D-Galactose-d1 | / | Unkown | |
| HY-N0210S6 | D-Galactose-d1-1 | 99.55% | Unkown | |
| HY-N0210S8 | D-Galactose-d1-3 | / | Unkown | |
| HY-N0215S13 | L-Phenylalanine-d1 | Antagonist | 99.5% | Unkown |
| HY-N0378S5 | D-Mannitol-d1 | / | Unkown | |
| HY-N0384S4 | Homovanillic acid-d3-1 | / | Unkown | |
| HY-N0537S12 | Xylose-d1-3 | / | Unkown | |
| HY-N0537S13 | Xylose-d1-4 | / | Unkown | |
| HY-N0717S8 | L-Valine-d1 | 98.0% | Unkown | |
| HY-N1380S4 | Guaiacol-d4-1 | / | Unkown | |
| HY-N6709S2 | Zeranol-d5-1 | / | Unkown | |
| HY-N7092S18 | D-Fructose-d2-1 | / | Unkown | |
| HY-P10215 | Ac-{Cpg}-Thr-Ala-{Ala(CO)}-Asp-{Cpg}-NH2 | Inhibitor | / | Unkown |
| HY-RS13999 | SUB1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W004292S1 | 1-Undecanol-d4 | / | Unkown | |
| HY-W004293S | 1-Tridecanol-d27 | 98.7% | Unkown | |
| HY-W005926S | 1,5-Dimethyl-1H-pyrazole-4-carboxylic acid-d6 | / | Unkown | |
| HY-W007926S | 2-Oxobutanoic acid-13C,d2-1 | / | Unkown | |
| HY-W008625S1 | 1-Bromohexadecane-d33 | / | Unkown | |
| HY-W009141S | 1-Monopalmitin-d31 | / | Unkown | |
| HY-W009450S | 1,7-Dibromoheptane-d14 | / | Unkown | |
| HY-W009570S | 1-Bromo-4-(trifluoromethoxy)benzene-d4 | / | Unkown | |
| HY-W009981S | 1-Bromo-2,4-difluorobenzene-d3 | / | Unkown | |
| HY-W010265S | Butyrophenone-d5 | / | Unkown | |
| HY-W011883S | 1,3-Dibromo-5-fluorobenzene-d3 | / | Unkown | |
| HY-W012856S | 1-Ethyl-3-methylbenzene-d5 | / | Unkown | |
| HY-W013053S | Dibenz[a,h]anthracene-d14 | / | Unkown | |
| HY-W013948S | 1-(2,4-Dinitrophenyl)-2-propylidenehydrazine-d3 | / | Unkown | |
| HY-W014409S | 1,2,4-Benzenetricarboxylic acid-d3 | / | Unkown | |
| HY-W014431S | 1-Bromo-3-chloro-5-fluorobenzene-d3 | / | Unkown | |
| HY-W014559S3 | 1-Bromononane-d4-1 | / | Unkown | |
| HY-W014559S4 | 1-Bromononane-d5 | / | Unkown | |
| HY-W015784S | 1,4-Benzenedimethanol-d4 | 98.0% | Unkown | |
| HY-W015824S3 | DL-Aspartic acid-13C1 | / | Unkown | |
| HY-W015849S | 1-Fluoro-4-methoxybenzene-d4 | / | Unkown | |
| HY-W016249S1 | 1-Bromo-4-ethylbenzene-d5 | / | Unkown | |
| HY-W016577S3 | 1-Bromoheptane-d7 | / | Unkown | |
| HY-W016577S4 | 1-Bromoheptane-d1 | / | Unkown | |
| HY-W016931S | 1-Bromo-4-chlorobutane-d8 | / | Unkown | |
| HY-W017142S | 1-(Benzyloxy)propan-2-ol-d6 | / | Unkown | |
| HY-W017522S5 | Adipic acid-d4-1 | Inhibitor | / | Unkown |
| HY-W017554S | 1-Chloro-2-methoxybenzene-d3 | / | Unkown | |
| HY-W032015S3 | 1-Bromooctane-d4 | 98.0% | Unkown | |
| HY-W040193S2 | DSPC-d79 | 99.3% | Unkown | |
| HY-W040193S5 | DSPC-d9 | 99.0% | Unkown | |
| HY-W040193S6 | DSPC-d13 | 99.0% | Unkown | |
| HY-W048482S | rU Phosphoramidite-13C2,d1 | / | Unkown | |
| HY-W051547S | 1-(2-Chloropyridin-3-yl)ethanol-d4 | / | Unkown | |
| HY-W051547S1 | 1-(2-Chloropyridin-3-yl)ethanol-d3 | / | Unkown | |
| HY-W051547S2 | 1-(2-Chloropyridin-3-yl)ethanol-d1 | / | Unkown | |
| HY-W052227S | Fmoc-DL-Ala-OH-d1 | / | Unkown | |
| HY-W087024S | 1-Phenylpentane-d5 | / | Unkown | |
| HY-W094751S | 1-Pyrenamin-d9 | / | Unkown | |
| HY-W098448S | 1-Methylazepan-2-one-d3 | 99.7% | Unkown | |
| HY-W099504S | 1-Heptanol-d15 | 99.05% | Unkown | |
| HY-W099504S1 | 1-Heptanol-d7 | / | Unkown | |
| HY-W099504S2 | 1-Heptanol-d1 | / | Unkown | |
| HY-W099521S | 1-Chlorooctane-d17 | 99.5% | Unkown | |
| HY-W101642S | 1,3-Diisopropylbenzene-d18 | / | Unkown | |
| HY-W101971S | 1-(4-Chlorophenyl)-2-methylpropan-2-ol-d6 | / | Unkown | |
| HY-W105111S | 1-Bromo-2,3,5-trichlorobenzene-d2 | / | Unkown | |
| HY-W110702S1 | 1-Bromotridecane-d4 | 99.2% | Unkown | |
| HY-W111467S | 1-Bromoeicosane-d41 | 99.9% | Unkown | |
| HY-W111468S | 1-Iodohexadecane-d4 | / | Unkown | |
| HY-W1125030S | Ethyl acetoacetate-13C2-1 | / | Unkown | |
| HY-W130478S | 1-Phenylhexane-d5 | / | Unkown | |
| HY-W142175S | 1-Butynylbenzene-d5 | 98.6% | Unkown | |
| HY-W583868S | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PE-d62 | / | Unkown | |
| HY-W590534S | 1-Palmitoyl-sn-glycero-3-phosphocholine-d3 | / | Unkown | |
| HY-W654074 | 1,2-Dilauroyl-3-chloropropanediol-d5 | / | Unkown | |
| HY-W699416 | 1-Naphthoic acid-d7 | / | Unkown | |
| HY-W699983 | Imidazole-15N2 | Inhibitor | 98.56% | Unkown |
| HY-W700931 | 1-Methoxy-2-(2-methoxyethoxy)ethane-d6 | / | Unkown | |
| HY-W700950 | 1-(4-Chlorophenyl)cyclobutanecarbonitrile-d6 | / | Unkown | |
| HY-W709612 | Regorafenib N-oxide and N-desmethyl (M5)-d3-1 | / | Unkown | |
| HY-W711089 | Bifenox-d3-1 | / | Unkown | |
| HY-W712592 | 1-Ethylpyrrolidine-2,5-dione-d5 | / | Unkown | |
| HY-W716213 | 1-(2,4-Dimethoxyphenyl)ethanone-d6 | / | Unkown | |
| HY-W718041S | 1-Lauroyl-2-decanoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W718042 | 1-Lauroyl-2-decanoyl-3-chloropropanediol-d5 | / | Unkown | |
| HY-W719338 | Pentane-1,2-diol-d7 | / | Unkown | |
| HY-W720915 | N-Dodecylbenzene-d5 | / | Unkown | |
| HY-W723927 | 1-Bromohexadecane-d4 | / | Unkown | |
| HY-W723937 | 1-Bromopentadecane-d4 | / | Unkown | |
| HY-W724365 | 1-Bromo-2-methoxyethane-d3 | / | Unkown | |
| HY-W724366 | 1-Ethyl-2-methylbenzene-d5 | / | Unkown | |
| HY-W724384 | 1-Bromotridecane-d9 | / | Unkown | |
| HY-W725429 | 1,5-Dihydroxynaphthalene-d6 | / | Unkown | |
| HY-W740373 | 1-Methylpiperidin-4-ol-d4 | / | Unkown | |
| HY-W749377 | 1,2,3,4,5-Pentabromo-6-methylbenzene-13C6 | / | Unkown | |
| HY-W751665 | 1-(Adamantan-1-yl)ethan-1-one-d3 | / | Unkown | |
| HY-W752616 | 1-Aminopropan-2-ol-d6 | / | Unkown | |
| HY-W752893 | D-4-Hydroxyphenylglycine-d5-1 | / | Unkown | |
| HY-W754348 | 1-(2,6-Dimethylphenoxy)propan-2-one-d5 | / | Unkown | |
| HY-W765245 | Rapamycin-13C,d3-1 | / | Unkown | |
| HY-W766078 | 1-beta-D-Arabinofuranosyluracil-13C,15N2 | / | Unkown | |
| HY-W766801 | 1-Linoleoyl-3-chloropropanediol-d5 | / | Unkown | |
| HY-W767978 | 1-(4,4-Dimethylthiochroman-6-yl)ethanone-d8 | / | Unkown | |
| HY-W768181 | 1,5-Anhydrosorbitol-13C6 | / | Unkown | |
| HY-W770203 | 1-Oleoyl-2-linoleoyl-rac-glycerol-d5 | / | Unkown | |
| HY-W777094 | 1-Acetyl-4-(4-hydroxyphenyl)piperazine-d8 | / | Unkown | |
| HY-W777620 | 1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C,d3 | / | Unkown | |
| HY-W777706 | 1-(3,4-Dimethylphenyl)ethan-1-ol-13C,d3 | / | Unkown | |
| HY-W778692 | 1-Linoleoyl Glycerol-d5 | / | Unkown | |
| HY-W778954 | 2,2-Dimethyl-1,3-dioxolane-4-methanol-13C3 | / | Unkown | |
| HY-Y0001S1 | Cyclopropylcarboxylic acid-d1 | / | Unkown | |
| HY-Y0093S | NSC 5416-d14 | / | Unkown | |
| HY-Y0219S | 1,2,4-Triazole-13C2,15N3 | / | Unkown | |
| HY-Y0219S1 | 1,2,4-Triazole-d3 | 99.8% | Unkown | |
| HY-Y0531S | 1-Adamantanol-d15 | / | Unkown | |
| HY-Y0727S | 1,5-Dibromopentane-d4 | / | Unkown | |
| HY-Y0727S1 | 1,5-Dibromopentane-d10 | / | Unkown | |
| HY-Y0860S | 1,6-Dibromo-n-hexane-d12 | / | Unkown | |
| HY-Y0921S1 | (±)-1,2-Propanediol-d2 | / | Unkown | |
| HY-Y0921S3 | (±)-1,2-Propanediol-13C3 | / | Unkown | |
| HY-Y1004S3 | 1-Decanol-d5 | / | Unkown | |
| HY-Y1039S | 1-Stearoyl-rac-glycerol-d40 | / | Unkown | |
| HY-Y1044S | 1,5-Dihydroxypentane-d10 | / | Unkown | |
| HY-Y1139S | Pimelic acid-d4 | / | Unkown | |
| HY-Y1217S | 1-Cyclohexanol-d12 | / | Unkown | |
| HY-Y1227S | 1-Methoxy-2-(2-methoxyethoxy)ethane-d14 | / | Unkown | |
| HY-Y1309S | 1-Naphthol-d8 | / | Unkown | |
| HY-Y1641S | 1,2-Ethanedithiol-d4 | / | Unkown | |
| HY-Y1772S | 1-Iodo-4-methylbenzene-d7 | / | Unkown | |
| HY-Y1809S | 1-Hydroxyoctadecane-d37 | / | Unkown | |
| HY-Y1809S1 | 1-Hydroxyoctadecane-d2 | / | Unkown | |
| HY-109037S2 | Mavacamten-d1 | Modulator | / | Unkown |
| HY-112675S | 4-Octyl itaconate-13C5-1 | / | Unkown | |
| HY-113482S | 1β-Hydroxydeoxycholic acid-d5 | / | Unkown | |
| HY-114553S | 1-(5-Fluoropentyl)-1H-indole-3-carboxylic acid-d5 | / | Unkown | |
| HY-124891S | 1-Phenylpyrrole-d9 | / | Unkown | |
| HY-128429S | trans-2-Hexenal-d2-1 | Inhibitor | / | Unkown |
| HY-128792S | 1,3-Dipalmitin-d6 | 98.0% | Unkown | |
| HY-130462S2 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-13C16 | / | Unkown | |
| HY-130462S3 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d64 | / | Unkown | |
| HY-13331S2 | Clascoterone-d5-1 | Antagonist | / | Unkown |
| HY-134178S1 | 5-F-UTP-13C,19F,d1 | / | Unkown | |
| HY-13631ES2 | Deruxtecan-d4-1 | / | Unkown | |
| HY-141636S | 1-PalMitoyl-2-arachidoyllecithin-d9-1 | / | Unkown | |
| HY-145473S | 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE-d11 | / | Unkown | |
| HY-14649S6 | Retinoic acid-d3-1 | Agonist | / | Unkown |
| HY-146829S | 1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phosphate-d7 sodium | / | Unkown | |
| HY-17043S2 | Loratadine-d4-1 | / | Unkown | |
| HY-19822S1 | Elacestrant-d4-1 | Inhibitor | / | Unkown |
| HY-34487S3 | 1,3-Dimethoxybenzene-d3 | / | Unkown | |
| HY-41700S2 | D-Alanine-d1 | / | Unkown | |
| HY-78004S1 | 1,2-Diphenylethane-d4 | / | Unkown | |
| HY-79779S | 1-Bromo-4-(bromomethyl)benzene-d6 | 99.56% | Unkown | |
| HY-B0122SS1 | Topiramate-13C6-1 | / | Unkown | |
| HY-B0141S6 | Estradiol-d2-1 | Agonist | / | Unkown |
| HY-B0197S | Naratriptan-d3 | Agonist | / | Unkown |
| HY-B0258S1 | Gemfibrozil-d6-1 | / | Unkown | |
| HY-B0479S1 | Thiamphenicol-d3-1 | 99.0% | Unkown | |
| HY-B0801S4 | Fexofenadine-d3-1 | Antagonist | / | Unkown |
| HY-B1812S4 | Veratrole-d2-1 | Substrate | / | Unkown |
| HY-D0837S | Imidazole-d4 | 99.94% | Unkown | |
| HY-N0229S19 | L-Alanine-1,2-13C2-1 | / | Unkown | |
| HY-N7092S23 | D-Fructose-13C3-1 | / | Unkown | |
| HY-RS18793 | Sub1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25282 | Sub1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W009293S | 1-(Bis(4-fluorophenyl)methyl)piperazine-d4 | / | Unkown | |
| HY-W011885S | 1-Dodecylpyrrolidin-2-one-d6 | / | Unkown | |
| HY-W012477S | 1-Hydroxycyclohexyl phenyl ketone-d5 | / | Unkown | |
| HY-W012652S | 1,2,3,4-Tetrahydroquinoxaline-d4 | / | Unkown | |
| HY-W015609S | 1-(2-Methoxyphenyl)ethanone-d3 | / | Unkown | |
| HY-W016152S | 1-Bromo-3-methoxybenzene-d3 | / | Unkown | |
| HY-W032013S2 | 1-Octanol-d2-1 | Inhibitor | / | Unkown |
| HY-W032013S3 | 1-Octanol-d5 | Inhibitor | / | Unkown |
| HY-W040193S1 | DSPC-d74 | 99% | Unkown | |
| HY-W110726S | 1-Octen-3-one-d5 | / | Unkown | |
| HY-W110726S1 | 1-Octen-3-one-d3 | / | Unkown | |
| HY-W192474S | 1-(Furan-2-yl)ethane-1-thiol-d3 | / | Unkown | |
| HY-W285163S | 1-Cyclopropyl-6-fluoro-7-(4-formylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid-d8 | / | Unkown | |
| HY-W342440S | 1,1-Diethoxynonane-d10 | / | Unkown | |
| HY-W654320 | Piperin-d10 | / | Unkown | |
| HY-W654409 | 1,1,1,3,3,3-Hexafluoropropan-2-ol-d2 | / | Unkown | |
| HY-W662572S | Pyroxsulam-d6 | / | Unkown | |
| HY-W743123 | 1,3-Dipalmitin-d5 | / | Unkown | |
| HY-W756596 | 1,2-Dioctanoyl-3-chloropropanediol-d5 | / | Unkown | |
| HY-W762019S | 1,2,3,4,7,8-Hexachloro dibenzo-p-dioxin-13C12 | / | Unkown | |
| HY-W777599 | (±)-Naproxen-13C,d3-1 | / | Unkown | |
| HY-W777649 | Oxypurinol-13C,15N2-1 | Inhibitor | / | Unkown |
| HY-Y0045S | 2-Acetylthiazole-13C2 | / | Unkown | |
| HY-Y0659S | 1,2,3,4-Hydroquinoline-d2 | / | Unkown | |
| HY-Y0678S | 1,3,5-Trimethoxybenzene-d3 | / | Unkown | |
| HY-Y0743S | 1-(Pyridin-2-yl)ethan-1-one-d6 | / | Unkown | |
| HY-Y1004S | 1-Decanol-d3 | / | Unkown | |
| HY-Y1004S1 | 1-Decanol-d2 | / | Unkown | |
| HY-Y1309S1 | 1-Naphthol-d7 | 99.44% | Unkown | |
| HY-Y1805S | 1,2,3,4-Tetrahydronaphthalene-d4 | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service